Transforming Pharma: Insights from Frontiers Health 2025

Digital

Digital health and digital therapeutics have been around for a long time now. But when will we really start to realise the promise of these tools?

pharmaphorum caught up with Emre Ozcan (Merck Group) after his onstage session at Frontiers Health dealing with this topic, which also included Merck Group’s Alessandro De Luca.

Ozcan gets into:

How demand and adoption for digital tools and services is changing the healthcare landscape
Increasing interest from payers in outcomes-based models
Figuring out the right hooks to bring patients and HCPs onboard with digital tools

Watch the full interview to hear from a top voice doing the work in digital health and digital therapeutics at a major pharma company.

Nicole Raleigh

26 November, 2025

FH25

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.